REDWOOD CITY, Calif., July 21 (San Francisco News Online) — A brain-tumor discovery on a preventive scan can sound like a reason to schedule a full-body MRI right away. But federal regulators and major medical groups say that one dramatic case does not change the larger question: for people without symptoms or known high risk, routine whole-body MRI screening still has no proven net benefit.
That debate matters in San Francisco, where CBS San Francisco reported on the growing popularity of Prenuvo full-body MRI scans and quoted a UCSF radiology researcher warning that there is not evidence the scans help people live longer or better. The local coverage reflects a national question many patients now face: does early detection outweigh the chance of false alarms?
What a full-body MRI is
A full-body, or total-body, MRI is an imaging exam that takes pictures of many parts of the body in one session. Companies that sell the scans promote them as a way to look for cancer, heart disease and other problems before symptoms appear.
The appeal is easy to understand. In some cases, imaging can find a serious problem early. Fox News recently reported on a former “Bachelor” contestant who said a preventive scan found a brain tumor before symptoms showed up.
But health agencies and specialty societies say that an isolated success story does not prove the test should be used as routine screening for everyone.
Why doctors are cautious
The Food and Drug Administration says it knows of no scientific evidence showing that whole-body scanning of people without symptoms provides more benefit than harm. The American College of Radiology says there is not enough evidence to recommend total-body screening for patients who have no symptoms, no risk factors and no family history suggesting disease. The American Academy of Family Physicians and the American College of Preventive Medicine also recommend against using full-body scans for early tumor detection in people without symptoms.
In a JAMA editorial reported by ABC News, radiology experts Matthew Davenport and Dr. Scott Reeder said no major medical group recommends whole-body MRI for the general population because the benefits remain unproven.
What can go wrong
The biggest concern is not the scan itself, but what happens after it. The American Cancer Society says MRI does not use ionizing radiation, unlike CT scans, but it can still produce findings that are hard to interpret.
Those findings may be false positives, meaning something looks suspicious but turns out not to be cancer or another serious disease. They may also be incidental findings, often called incidentalomas, which are unexpected spots or shadows that may have nothing to do with the reason for the scan. The American Cancer Society says such findings can lead to anxiety, more testing, and sometimes procedures that were never needed.
Dr. Rebecca Smith-Bindman of UCSF told CBS San Francisco that there is “not a stitch of evidence” that the scans help people live longer or better, and she warned that they can create “tremendous numbers of false positives.” She said that can send people into follow-up testing for abnormalities that may never matter.
The American Cancer Society says the risk comes from those downstream effects, including unnecessary scans, biopsies or other procedures. Cleveland Clinic says there is also a risk of overdiagnosis, which means finding a condition that would not have caused major symptoms or death.
What about cost and insurance?
The American Cancer Society says insurance companies rarely pay for full-body MRI because it is not part of standard medical care. That means many people who choose the scan may have to pay out of pocket.
Why the local angle matters
In the Bay Area, full-body MRI companies have drawn attention from health influencers and consumers looking for reassurance. CBS San Francisco reported that Prenuvo has promoted its scans as a way to detect more than 500 conditions, including early-stage tumors, but UCSF’s Smith-Bindman said there is no evidence the test changes outcomes for healthy people.
That tension is at the center of the national debate. A scan that catches one rare cancer early may seem like a win. But the FDA and major medical groups say the bigger picture still does not show that routine screening helps more than it harms for people who do not have symptoms or a specific medical reason to be scanned.
For now, the most consistent message from regulators and specialty societies is that whole-body MRI is not a standard screening test for the general population, even if it can sometimes find something serious by chance.
